BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 30997832)

  • 1. IL-25 contributes to lung fibrosis by directly acting on alveolar epithelial cells and fibroblasts.
    Xu X; Luo S; Li B; Dai H; Zhang J
    Exp Biol Med (Maywood); 2019 Jun; 244(9):770-780. PubMed ID: 30997832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblastic foci, covered with alveolar epithelia exhibiting epithelial-mesenchymal transition, destroy alveolar septa by disrupting blood flow in idiopathic pulmonary fibrosis.
    Yamaguchi M; Hirai S; Tanaka Y; Sumi T; Miyajima M; Mishina T; Yamada G; Otsuka M; Hasegawa T; Kojima T; Niki T; Watanabe A; Takahashi H; Sakuma Y
    Lab Invest; 2017 Mar; 97(3):232-242. PubMed ID: 27941755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compartmentalized expression of c-FLIP in lung tissues of patients with idiopathic pulmonary fibrosis.
    Cha SI; Groshong SD; Frankel SK; Edelman BL; Cosgrove GP; Terry-Powers JL; Remigio LK; Curran-Everett D; Brown KK; Cool CD; Riches DW
    Am J Respir Cell Mol Biol; 2010 Feb; 42(2):140-8. PubMed ID: 19372246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs.
    Marudamuthu AS; Shetty SK; Bhandary YP; Karandashova S; Thompson M; Sathish V; Florova G; Hogan TB; Pabelick CM; Prakash YS; Tsukasaki Y; Fu J; Ikebe M; Idell S; Shetty S
    J Biol Chem; 2015 Apr; 290(15):9428-41. PubMed ID: 25648892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-25/IL-33/TSLP contributes to idiopathic pulmonary fibrosis: Do alveolar epithelial cells and (myo)fibroblasts matter?
    Xu X; Zhang J; Dai H
    Exp Biol Med (Maywood); 2020 May; 245(10):897-901. PubMed ID: 32249602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Participation of miR-200 in pulmonary fibrosis.
    Yang S; Banerjee S; de Freitas A; Sanders YY; Ding Q; Matalon S; Thannickal VJ; Abraham E; Liu G
    Am J Pathol; 2012 Feb; 180(2):484-93. PubMed ID: 22189082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bile acids induce activation of alveolar epithelial cells and lung fibroblasts through farnesoid X receptor-dependent and independent pathways.
    Chen B; Cai HR; Xue S; You WJ; Liu B; Jiang HD
    Respirology; 2016 Aug; 21(6):1075-80. PubMed ID: 27185272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL9 Regulates TGF-β1-Induced Epithelial to Mesenchymal Transition in Human Alveolar Epithelial Cells.
    O'Beirne SL; Walsh SM; Fabre A; Reviriego C; Worrell JC; Counihan IP; Lumsden RV; Cramton-Barnes J; Belperio JA; Donnelly SC; Boylan D; Marchal-Sommé J; Kane R; Keane MP
    J Immunol; 2015 Sep; 195(6):2788-96. PubMed ID: 26268659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingosine-1-phosphate is increased in patients with idiopathic pulmonary fibrosis and mediates epithelial to mesenchymal transition.
    Milara J; Navarro R; Juan G; Peiró T; Serrano A; Ramón M; Morcillo E; Cortijo J
    Thorax; 2012 Feb; 67(2):147-56. PubMed ID: 22106015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential role of interleukin (IL)-25/IL-33/thymic stromal lymphopoietin (TSLP) on the pathogenesis of idiopathic pulmonary fibrosis.
    Xu X; Dai H; Zhang J
    Clin Respir J; 2022 Nov; 16(11):696-707. PubMed ID: 36082495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCR3 Requirement for the Interleukin-13-Mediated Up-Regulation of Interleukin-13Rα2 in Pulmonary Fibroblasts.
    Barnes JC; Lumsden RV; Worrell J; Counihan IP; O'Beirne SL; Belperio JA; Fabre A; Donnelly SC; Boylan D; Kane R; Keane MP
    Am J Respir Cell Mol Biol; 2015 Aug; 53(2):217-25. PubMed ID: 25514189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased alveolar soluble annexin V promotes lung inflammation and fibrosis.
    Buckley S; Shi W; Xu W; Frey MR; Moats R; Pardo A; Selman M; Warburton D
    Eur Respir J; 2015 Nov; 46(5):1417-29. PubMed ID: 26160872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cells correct inappropriate epithelial-mesenchyme relation in pulmonary fibrosis using stanniocalcin-1.
    Ono M; Ohkouchi S; Kanehira M; Tode N; Kobayashi M; Ebina M; Nukiwa T; Irokawa T; Ogawa H; Akaike T; Okada Y; Kurosawa H; Kikuchi T; Ichinose M
    Mol Ther; 2015 Mar; 23(3):549-60. PubMed ID: 25373521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-4 increases CD21-dependent infection of pulmonary alveolar epithelial type II cells by EBV.
    Malizia AP; Egan JJ; Doran PP
    Mol Immunol; 2009 May; 46(8-9):1905-10. PubMed ID: 19193442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of PTEN induces lung fibrosis via alveolar epithelial cell senescence depending on NF-κB activation.
    Tian Y; Li H; Qiu T; Dai J; Zhang Y; Chen J; Cai H
    Aging Cell; 2019 Feb; 18(1):e12858. PubMed ID: 30548445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingosine-1-phosphate receptor-2 facilitates pulmonary fibrosis through potentiating IL-13 pathway in macrophages.
    Zhao J; Okamoto Y; Asano Y; Ishimaru K; Aki S; Yoshioka K; Takuwa N; Wada T; Inagaki Y; Takahashi C; Nishiuchi T; Takuwa Y
    PLoS One; 2018; 13(5):e0197604. PubMed ID: 29782549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis.
    Kim TH; Lee YH; Kim KH; Lee SH; Cha JY; Shin EK; Jung S; Jang AS; Park SW; Uh ST; Kim YH; Park JS; Sin HG; Youm W; Koh ES; Cho SY; Paik YK; Rhim TY; Park CS
    Am J Respir Crit Care Med; 2010 Sep; 182(5):633-42. PubMed ID: 20463180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recapitulating idiopathic pulmonary fibrosis related alveolar epithelial dysfunction in a human iPSC-derived air-liquid interface model.
    Schruf E; Schroeder V; Le HQ; Schönberger T; Raedel D; Stewart EL; Fundel-Clemens K; Bluhmki T; Weigle S; Schuler M; Thomas MJ; Heilker R; Webster MJ; Dass M; Frick M; Stierstorfer B; Quast K; Garnett JP
    FASEB J; 2020 Jun; 34(6):7825-7846. PubMed ID: 32297676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grainyhead-like 2 (GRHL2) distribution reveals novel pathophysiological differences between human idiopathic pulmonary fibrosis and mouse models of pulmonary fibrosis.
    Varma S; Mahavadi P; Sasikumar S; Cushing L; Hyland T; Rosser AE; Riccardi D; Lu J; Kalin TV; Kalinichenko VV; Guenther A; Ramirez MI; Pardo A; Selman M; Warburton D
    Am J Physiol Lung Cell Mol Physiol; 2014 Mar; 306(5):L405-19. PubMed ID: 24375798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of the mouse model of acute exacerbation of idiopathic pulmonary fibrosis.
    Wei YR; Qiu H; Wu Q; Du YK; Yin ZF; Chen SS; Jin YP; Zhao MM; Wang C; Weng D; Li HP
    Exp Lung Res; 2016; 42(2):75-86. PubMed ID: 27070485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.